Companies (34)

INGERSOLL RAND INC.
Logo Ingersoll Rand Inc.

Ingersoll Rand Inc. specializes in the design, manufacture and marketing of industrial technological equipment. The group provides compressed air equipment (screw compressors, reciprocating compressors, centrifugal compressors, air dryers, air filters, et ...

Capitalization 37 539 M USD
Change+1.14%
1-year price change+20.31%
INTERNATIONAL STAR, INC.
Logo International Star, Inc.

International Star, Inc. operates, through its wholly owned subsidiary, Budding Equity Inc., a royalty-based business that owns intellectual property contracts with movie studios, which provide for the licensing of that intellectual property (IP) to third ...

Capitalization 4 M USD
Change+10.47%
1-year price change+533.33%
MADRIGAL PHARMACEUTICALS, INC.
Logo Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH). The Company's product candidate, resmetirom, is a once-daily, oral, liver-directe ...

Capitalization 5 033 M USD
Change+4.73%
1-year price change+2.07%
CYTODYN INC.
Logo CytoDyn Inc.

CytoDyn Inc. is a clinical-stage biotechnology company. The Company is focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (C ...

Capitalization 157 M USD
Change-28.97%
1-year price change-19.08%
VIKING THERAPEUTICS, INC.
Logo Viking Therapeutics, Inc.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company that is focused on the development of therapies for treatment of metabolic and endocrine disorders. The Company's clinical programs include VK2809, an orally available, small molecule ...

Capitalization 6 865 M USD
Change+0.78%
1-year price change+234.55%
ASCLETIS PHARMA INC.
Logo Ascletis Pharma Inc.

Ascletis Pharma Inc is a China-based investment holding company principally engaged in the research, development, production, marketing and sales of pharmaceutical products. The Company mainly focuses on viral diseases, non-alcoholic steatohepatitis (NASH ...

Capitalization 157 M USD
Change-0.82%
1-year price change-17.12%
NASH DOM BULGARIA HOLDING AD
Logo Nash Dom Bulgaria Holding AD

Nash Dom Bulgaria Holding AD Sofia (Nash Dom-Bulgaria AD-Holding or Nash Dom Bulgaria Holding PLC) is a Bulgaria-based holding company that is principally engaged in the acquisition, appraisal and managing of shares in companies active in the food process ...

Capitalization 185 428 USD
Change+17.31%
1-year price change-.--%
POXEL
Logo Poxel

Poxel is a biopharmaceutical company specializing in developing innovative treatments for metabolic diseases, including non-alcoholic steatohepatitis (NASH) and rare diseases. TWYMEEG® (Imeglimine), Poxel's lead product and the first in its class of medi ...

Capitalization 32 M USD
Change+0.48%
1-year price change+13.97%
INVENTIVA
Logo Inventiva

Inventiva is a biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical need in the areas of fibrosis, lysosomal storage disorders and oncology. The group is develop ...

Capitalization 188 M USD
Change+3.93%
1-year price change-19.29%
GELESIS HOLDINGS, INC.
Logo Gelesis Holdings, Inc.

Gelesis Holdings, Inc. is a commercial stage biotherapeutics company built for consumer engagement. The Company focuses on advancing superabsorbent hydrogel therapeutics for chronic gastrointestinal (GI) diseases including excess weight, type two diabetes ...

Capitalization 73 USD
Change-99.99%
1-year price change-99.93%
HEPION PHARMACEUTICALS, INC.
Logo Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development of drug therapy for treatment of chronic liver diseases. The Company is developing a treatment for non-alcoholic steatohepatitis (NASH), hepatocellular c ...

Capitalization 7 M USD
Change+1.61%
1-year price change-61.11%
GALMED PHARMACEUTICALS LTD.
Logo Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals is a Israeli-based clinical-stage biopharmaceutical company.The activiti of the Company is focused on the development therapy for treating liver diseases. Arachmol, the main product of Galmed Pharmaceuticals, is a liver-targeted ste ...

Capitalization 2 M USD
Change+1.65%
1-year price change-18.66%
BELITE BIO, INC
Logo Belite Bio, Inc

Belite Bio, Inc is a clinical-stage biopharmaceutical drug development company. The Company is focused on advancing novel therapeutics targeting retinal degenerative eye disease, such as atrophic age-related macular degeneration (AMD), and autosomal reces ...

Capitalization 1 458 M USD
Change+0.41%
1-year price change+6.99%
TAPINATOR, INC.
Logo Tapinator, Inc.

Tapinator, Inc. develops and publishes games for mobile platforms. The Company’s portfolio includes over 300 titles that have over 500 million mobile downloads, including games such as Video Poker Classic and Crypto Trillionaire. It publishes two types ...

Capitalization 1 M USD
Change-3.85%
1-year price change-23.05%
VALBIOTIS
Logo VALBIOTIS

VALBIOTIS is a French Research & Development company committed to scientific innovation for the prevention and control of metabolic diseases. VALBIOTIS specializes in the development of innovative nutritional solutions for cardio-metabolic disease prevent ...

Capitalization 67 M USD
Change-1.27%
1-year price change-22.20%
GALECTIN THERAPEUTICS INC.
Logo Galectin Therapeutics Inc.

Galectin Therapeutics, Inc. is a clinical stage biopharmaceutical company dedicated to developing novel therapies to improve the lives of patients with chronic liver disease and cancer. The Company's drug candidates are based on its method of targeting ga ...

Capitalization 168 M USD
Change-.--%
1-year price change+63.86%
89BIO, INC.
Logo 89bio, Inc.

89bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. The Company’s lead product candidate, pegozafermin, a speci ...

Capitalization 776 M USD
Change+1.41%
1-year price change-29.36%
LIPOCINE INC.
Logo Lipocine Inc.

Lipocine Inc. is a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery to develop differentiated products for Central Nervous System (CNS) disorders. Its clinical development can ...

Capitalization 37 M USD
Change-0.14%
1-year price change+148.03%
MARVEL BIOSCIENCES CORP.
Logo Marvel Biosciences Corp.

Marvel Biosciences Corp. is a Canada-based pre-clinical-stage pharmaceutical development biotechnology company. The Company develops new synthetic chemical derivatives of the original approved drug for the new disease indication. It has developed several ...

Capitalization 3 M USD
Change-4.55%
1-year price change+31.25%
THERATECHNOLOGIES INC.
Logo Theratechnologies Inc.

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunode ...

Capitalization 58 M USD
Change-1.16%
1-year price change-20.09%
UKRPRODUCT GROUP LIMITED
Logo Ukrproduct Group Limited

Ukrproduct Group Limited is a Jersey-based holding company for a group of food and beverage businesses located in Ukraine. The principal activities of the Company are the production and distribution of branded dairy foods and beverages (kvass) in Ukraine ...

Capitalization 2 M USD
Change-.--%
1-year price change-.--%
CATALYST BIOSCIENCES
Logo Catalyst Biosciences

Catalyst Biosciences, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of Hydronidone for the treatment of nonalcoholic steatohepatitis (NASH), a severe form of nonalcoholic fatty liver disease in the Un ...

Capitalization 19 M USD
Change+9.13%
1-year price change+48.12%
BIOSTAX CORP.
Logo Biostax Corp.

Biostax Corp. is a developer and marketer of pharmaceutical, biotechnology, and MedTech products. The Company has partnerships in the fields of autoimmunity and immune restoration and are able to deliver solutions today for people that are living with aut ...

Capitalization 3 M USD
Change+6.06%
1-year price change-52.05%
VECTUS BIOSYSTEMS LIMITED
Logo Vectus Biosystems Limited

Vectus Biosystems Limited is an Australia-based drug discovery and development company. The Company focuses on medical research and development. It is engaged in developing a treatment for fibrosis and high blood pressure, which includes the treatment for ...

Capitalization 5 M USD
Change-.--%
1-year price change-56.67%
THIOGENESIS THERAPEUTICS, CORP.
Logo Thiogenesis Therapeutics, Corp.

Thiogenesis Therapeutics, Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is engaged in developing thiol-active therapeutic compounds, which are prodrugs used to treat unmet pediatric medical needs. The Company’s lead compo ...

Capitalization 23 M USD
Change+1.45%
1-year price change-6.67%
PLIANT THERAPEUTICS, INC.
Logo Pliant Therapeutics, Inc.

Pliant Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on discovering and developing therapies for the treatment of fibrosis and related diseases. Its lead product candidate, bexotegrast (PLN-74809), is an oral, small ...

Capitalization 732 M USD
Change-0.33%
1-year price change-33.02%
LIN BIOSCIENCE, INC.
Logo Lin BioScience, Inc.

LIN BIOSCIENCE, INC. is a Taiwan-based company mainly engaged in the development of new pharmaceutical drugs. The Company is in the research and development and clinical trials stage. It has four major drugs in development, including LBS-008, LBS-007, LBS ...

Capitalization 222 M USD
Change-0.43%
1-year price change-19.47%
ALGERNON PHARMACEUTICALS INC.
Logo Algernon Pharmaceuticals Inc.

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), infl ...

Capitalization 3 M USD
Change+3.23%
1-year price change+146.15%
AGENTIX CORP.
Logo Agentix Corp.

Agentix Corp. is a clinical-stage biotechnology company. The Company is engaged in developing therapeutic agents for the treatment of metabolic diseases like Type 2 diabetes mellitus, obesity, non-alcoholic fatty liver disease (NAFLD) and non-alcoholic st ...

Capitalization 1 M USD
Change+54.13%
1-year price change+14.52%
ORAMED PHARMACEUTICALS INC.
Logo Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc. is a pharmaceutical company engaged in the research and development of pharmaceutical solutions with a technology platform. The Company has developed an oral dosage form intended to withstand the harsh environment of the stomac ...

Capitalization 89 M USD
Change-2.68%
1-year price change-5.63%
SYNTARA LIMITED
Logo Syntara Limited

Syntara Limited, formerly Pharmaxis Ltd, is an Australia-based clinical-stage drug development company with a focus on blood-related cancers. The Company’s highly productive drug discovery engine is driven by its expertise in amine oxidase inhibitors. I ...

Capitalization 16 M USD
Change-.--%
1-year price change-.--%
LEXINGTON GOLD LTD
Logo Lexington Gold Ltd

Lexington Gold Ltd is a gold exploration and development company. It holds interests in four diverse gold projects, covering a combined area of approximately 1,675 acres in North and South Carolina, United States and in five gold projects covering approxi ...

Capitalization 22 M USD
Change-.--%
1-year price change+9.52%
CALLINEX MINES INC.
Logo Callinex Mines Inc.

Callinex Mines Inc. is a Canada-based company. The Company is advancing its portfolio of base and precious metals-rich deposits located in Canadian mining jurisdictions. The focus of the portfolio is the Rainbow and Alchemist deposits at its volcanogenic ...

Capitalization 20 M USD
Change+11.19%
1-year price change-10.67%
SIAM SPORT SYNDICATE PUBLIC COMPANY
Logo Siam Sport Syndicate Public Company

Siam Sport Syndicate Public Company Limited is a Thailand-based company engaged in producing and selling of sport and entertainment media. The Company provides various types of media and related activities, including daily newspapers, sport and entertainm ...

Capitalization 898 848 USD
Change-
1-year price change-

12Next